Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances Vasculogenesis
The stem cell therapy for treating ischemic diseases is promising; however, the limited availability and compromised quality of progenitor cells in aged and diseased patients limit its therapeutic use. Here we report a nanofiber-based ex vivo stem cell expansion technology and proangiogenic growth f...
Main Authors: | Hiranmoy Das Ph.D., Nasreen Abdulhameed, Matthew Joseph, Ramasamy Sakthivel, Hai-Quan Mao, Vincent J. Pompili M.D., FACC |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-03-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368909788534870 |
Similar Items
-
Postnatal vasculogenesis : the role of endothelial progenitor cells
by: Lü, Xiaomei
Published: (2004) -
Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133+ Human Cord Blood Cells for Postnatal Vasculogenesis.
by: Mika Ishige-Wada, et al.
Published: (2016-01-01) -
Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
by: Jingwei Lu, et al.
Published: (2010-03-01) -
Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells
by: Bin Zhou, et al.
Published: (2007-03-01) -
Epigenetic Activation of Pro-angiogenic Signaling Pathways in Human Endothelial Progenitors Increases Vasculogenesis
by: Sylvain Fraineau, et al.
Published: (2017-11-01)